Foghorn Therapeutics (FHTX) Change in Acquisitions & Divestments (2021 - 2025)
Foghorn Therapeutics has reported Change in Acquisitions & Divestments over the past 5 years, most recently at $47.2 million for Q4 2025.
- Quarterly results put Change in Acquisitions & Divestments at $47.2 million for Q4 2025, down 24.36% from a year ago — trailing twelve months through Dec 2025 was $243.3 million (up 4.67% YoY), and the annual figure for FY2025 was $243.3 million, up 4.67%.
- Change in Acquisitions & Divestments for Q4 2025 was $47.2 million at Foghorn Therapeutics, up from $39.6 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for FHTX hit a ceiling of $94.5 million in Q2 2021 and a floor of $19.0 million in Q2 2022.
- Median Change in Acquisitions & Divestments over the past 5 years was $53.1 million (2022), compared with a mean of $52.7 million.
- Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 79.89% in 2022 and later skyrocketed 303.02% in 2023.
- Foghorn Therapeutics' Change in Acquisitions & Divestments stood at $20.0 million in 2021, then soared by 90.5% to $38.1 million in 2022, then grew by 16.17% to $44.3 million in 2023, then surged by 41.02% to $62.4 million in 2024, then dropped by 24.36% to $47.2 million in 2025.
- The last three reported values for Change in Acquisitions & Divestments were $47.2 million (Q4 2025), $39.6 million (Q3 2025), and $76.0 million (Q2 2025) per Business Quant data.